Deborah Doss
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in ⓘ
- Hematology 24
- Multiple Myeloma Research and Treatments 24
-
- Protein Degradation and Inhibitors 10
- Cancer therapeutics and mechanisms 4
- Ubiquitin and proteasome pathways 2
- Co-authors
- Kenneth C. Anderson (13 shared papers)Robert Schlossman (9 shared papers)Hani Doss (1 shared paper)Randall E. Harris (1 shared paper)Constantine S. Mitsiades (7 shared papers)Edie Weller (6 shared papers)Paul G. Richardson (10 shared papers)Andrea Freeman (4 shared papers)
- Journals
- Clinical journal of oncology nursing (6 papers)Blood (6 papers)Journal of Clinical Oncology (4 papers)Journal of Immunotherapy (1 paper)Cancer Nursing (1 paper)
- Partner nations
- United StatesIndiaGermany
In The Last Decade
Deborah Doss
33 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 1.3k
- Oncology 860
- Genetics 244
- Molecular Biology 1.1k
- Pharmacology 190
Countries citing papers authored by Deborah Doss
This map shows the geographic impact of Deborah Doss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Doss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Doss more than expected).
Fields of papers citing papers by Deborah Doss
This network shows the impact of papers produced by Deborah Doss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Doss. The network helps show where Deborah Doss may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah Doss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma Hit paper breakdown → | 2002 | 630 |
| 2 | 2005 | 337 | |
| 3 | 2009 | 200 | |
| 4 | 2001 | 165 | |
| 5 | 2001 | 152 | |
| 6 | 2009 | 127 | |
| 7 | 2004 | 96 | |
| 8 | Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy. | 1999 | 41 |
| 9 | 2004 | 31 | |
| 10 | 2005 | 27 | |
| 11 | 2009 | 27 | |
| 12 | 2017 | 26 | |
| 13 | A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM). | 2001 | 23 |
| 14 | 2008 | 14 | |
| 15 | 2008 | 13 | |
| 16 | 2011 | 10 | |
| 17 | Tailoring treatment for multiple myeloma patients with relapsed and refractory disease. | 2010 | 10 |
| 18 | 2024 | 8 | |
| 19 | 2012 | 8 | |
| 20 | 2006 | 7 |
About Deborah Doss
Deborah Doss is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (10 papers), Cancer Treatment and Pharmacology (9 papers), Peptidase Inhibition and Analysis (8 papers), Cancer therapeutics and mechanisms (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (860 citations), Genetics (244 citations), Molecular Biology (1.1k citations) and Pharmacology (190 citations). Deborah Doss has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Kenneth C. Anderson, Robert Schlossman, Hani Doss, Randall E. Harris, Constantine S. Mitsiades, Edie Weller, Paul G. Richardson, Andrea Freeman, Teru Hideshima and Mary McKenney. Their work appears in journals such as Clinical journal of oncology nursing, Blood, Journal of Clinical Oncology, Journal of Immunotherapy and Cancer Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.